Papers
19
Total Citations
917
H-Index
11
About
Alessandro Zerbi is a pioneering pancreatic surgeon whose research has reshaped the landscape of minimally invasive pancreatic surgery. His primary focus lies in comparing the oncological safety and perioperative outcomes of minimally invasive distal pancreatectomy (MIDP) against traditional open surgery, particularly for pancreatic ductal adenocarcinoma. Zerbi’s landmark contributions include leading the DIPLOMA trial, an international randomized non-inferiority study that demonstrated the oncological safety of MIDP for resectable pancreatic cancer, with its 2017 and 2023 publications amassing over 280 and 121 citations, respectively. He has also driven critical comparisons between robotic and laparoscopic approaches, showing the benefits of robotic assistance in complex resections. His work establishing the European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS) and defining benchmarks for spleen-preserving distal pancreatectomy has set global standards for quality and training. With multiple papers exceeding 100 citations and a focus on learning curves and outcomes in elderly patients, Zerbi’s research directly informs surgical practice, improving recovery and safety for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic <i>versus</i> laparoscopic distal pancreatectomy: multicentre analysis121 citations · 2021
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10